Immuno-Biological Laboratories Co., Ltd. (TYO:4570)
Japan flag Japan · Delayed Price · Currency is JPY
888.00
-9.00 (-1.00%)
Nov 18, 2026, 10:30 AM JST

TYO:4570 Cash Flow Statement

Millions JPY. Fiscal year is Apr - Mar.

Operating Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Net Income
346300209124-280-250
Depreciation & Amortization
1918152--
Loss (Gain) From Sale of Assets
-----6
Loss (Gain) From Sale of Investments
11---130-
Loss (Gain) on Equity Investments
----203152
Other Operating Activities
-2-2-6-10-8-8
Change in Accounts Receivable
-252-4132-4925
Change in Inventory
-85-614-3-6-15
Change in Accounts Payable
9-1-251-1
Change in Other Net Operating Assets
5-54-1735-2
Operating Cash Flow
30130118313326-93
Operating Cash Flow Growth
7.50%64.48%37.59%411.54%--

Investing Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Capital Expenditures
-14-33-59-16--
Divestitures
----77-
Sale (Purchase) of Intangibles
----2--
Investment in Securities
-281-835-65-6
Other Investing Activities
--1-31
Investing Cash Flow
-295-116-53-2430-155

Financing Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Short-Term Debt Issued
-2-55105
Long-Term Debt Issued
--2010-60
Total Debt Issued
7220155165
Long-Term Debt Repaid
--29-52-14-4-22
Net Debt Issued (Repaid)
-20-27-3211143
Other Financing Activities
-1-1-1-1-
Financing Cash Flow
-76-27-31--143

Net Cash Flow

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Foreign Exchange Rate Adjustments
---2221
Miscellaneous Cash Flow Adjustments
2-1-21542
Net Cash Flow
-6815795112112-102

Free Cash Flow

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Free Cash Flow
28726812411726-93
Free Cash Flow Growth
25.88%116.13%5.98%350.00%--
Free Cash Flow Margin
26.52%26.69%12.80%14.34%3.28%-14.37%
Free Cash Flow Per Share
30.8228.7813.3112.562.79-9.99
Levered Free Cash Flow
1431515564.13119.88-192.25
Unlevered Free Cash Flow
143.63151.6355.6364.75120.5-192.25

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash Interest Paid
11331-
Cash Income Tax Paid
455988
Change in Working Capital
-73-15-3517-197